curriculum vitae and lists of publications curriculum … · 1- quality of life assessment of adult...

1

CURRICULUM VITAE AND LISTS OF PUBLICATIONS CURRICULUM VITAE Full Name: Cafer Adıgüzel Date of Birth: April 10, 1967 Educational Status:

Degree Department/Program University Year

Bachelor’s Degree

Master’s Degree School of Medicine Cerrahpaşa School of Medicine,

Istanbul University 1990

Doctorate/Medical

Specialty Internal Medicine

Haydarpaşa Numune Training and

Research Hospital

1999

Doctorate/Medical

Specialty Hematology

School of Medicine, Marmara

University 2003

Associate

Professor Hematology

School of Medicine, Marmara

University 2011

Title of Master’s Degree Dissertation (abstract is attached) and Advisor(s):

“Serum iron and ferritin levels in ischemic heart disease” (Internal Medicine Specialty

Dissertation Thesis).

Thesis Advisor: Prof. Aydoğan Albayrak, M.D. Doctorate Dissertation/Qualification Study/Title of Medical Specialty

Dissertation (abstract is attached) and Advisor(s): “'Flow' cytometric analysis of

effects of leukocyte filtration, radiation and storage period of apheresis platelet

suspensions on platelet activation and apoptosis” (Hematology sub-specialty dissertation

thesis)

Thesis Advisor: Prof. Mahmut Bayık, M.D. Positions:

Position

Title

Place of Duty Year

Practitioner Gülçimen Community Clinic, Bulanık Merkez Community

Clinic (Muş) 1990-1992

Practitioner İpsala State Hospital, Emergency Medicine Clinic 1992-1994

Research

Assistant Internal Medicine, Haydarpaşa Numune Training and

Research Hospital, Internal Medicine 1994-1999

Specialist Beykoz State Hospital, Internist 1999-1999

Research

Assistant Department of Internal Medicine, School of Medicine,

Marmara University - Hematology 1999-2003

Specialist Department of Internal Medicine, School of Medicine,


Faculty

Member Department of Internal Medicine, School of Medicine,


Fellowship Department of Pathology, Hemostasis and Thrombosis

Research Laboratories, Loyola University Medical Center,

Maywood, Chicago, Illinois, USA,

2007-2009

Assoc. Prof. Department of Internal Medicine, School of Medicine,


Assoc. Prof. Head of Hematology and Bone Marrow Transplantation Unit,

Medicalpark Göztepe Hospital 2013 – to

date Prof Dr Head of Hematology and Bone Marrow Transplantation Unit,

Medicalpark Göztepe Hospital 2016 – to

date:

2

International Assignments: Fellowship in the field of Hemostasis and

Thrombosis (Fellowship), Department of Pathology, Hemostasis and Thrombosis

Research Laboratories, Loyola University Medical Center, Maywood, Chicago, Illinois,

USA, (June 1, 2007 – April 18, 2009)

Post-graduate thesis supervised: Effects of interim PET/CT evaluation on the disease

outcome in Diffuse Large B Cell Non-Hodgkin Lymphomas – Bülent Kantarcıoğlu

Doctorate thesis / Proficiency in Art studies supervised: Administrative Duties

2010-2013 Head of Blood Bank, Medical School Hospital, Marmara University

Duties undertaken in Projects: 1- Quality of Life Assessment of Adult Hematopoietic Stem Cell Transplantation

Recipients in Turkey – Impact of Cultural Differences, Co-researcher, (2004)

2- Comparison of endothelial progenitor cells in patients with Behçet’s disease with

healthy populations and prognostic significance of vascular involvement, Project

Executive, (2006)

3- Phase III study comparing standard dose Imatinib (400 mg) with high-dose Imatinib

(800) in treatment of newly diagnosed chronic phase, high-risk chronic myeloid

leukemia. A multi-center international study, Co-researcher (2006) 4- A multi-center, randomized Phase-III study investigating benefits of observation for

maintenance treatment with Rituximab after induction therapy with Rituximab and

chemotherapy in patients with advanced stage follicular lymphoma. A multi-center

international study, Co-researcher (2007)

Scientific Organization Memberships: Turkish Medical Association Turkish Society of Hematology

Turkish Society of Thrombosis, Hemostasis and Angiology

American Society of Hematology (ASH)

International Society on Hemostasis and Thrombosis (ISTH)

North American Thrombosis Forum (NATF)

Awards: Çetiner, M., Ovalı, E., Yavuz, M. N., Ratip, S., Kartı, S., Adıgüzel, C., Argon, D., Fıratlı-

Tuğlular, T., Bayık, M., “The role of Amifostine in preventing negative effect of radiation

on bone marrow and CD34+ cells”. XXVIII. “Best Paper Award in Experimental

Hematology”, Turkish Hematology Congress, November 2-4, 2000, İzmir Argon D, Yüksel M, Adıgüzel C, Sönmezoğlu M,, Yalçın S, Bayık M .”Effects of leukocyte

depletion, irradiation and storage times of apheresis platelet suspensions on free radical

formation”, XXX. Best Paper Award, Turkish Hematology Congress, XXX. Turkish

Hematology Congress, October 10-14, 2003, Istanbul

Scholarships

1. Turkish Society of Hematology, International Support Program Scholarship for

Hematology Residents / Specialist, May 2008

2. Fellow of International Union of Angiology (2008-2009)

3. Visiting fellow of the NATF (September 2008)

LETTERS/ARTICLES/PUBLICATIONS Articles published in international peer-review journals: A1. Kantarcıoğlu, B., Türköz, H. K., Yılmaz, G., Tanrıkulu, F. P., Atagündüz, I. K.,

Adıgüzel, C., & Tuğlular, T. F. (2014). Aplastic anemia associated with oral terbinafine:

a case report and review of the literature. Turkish Journal of Hematology, 31(4), 411.

3

A2. Akbas, T., Ozen, M., Adıguzel, C., Cimsit, N. C., & Karakurt, S. (2014). Cardiac

Calcification Following Severe Sepsis: A Case Report and Review of the Literature.

Journal of Anesthesia & Clinical Research, 2014. A3. Toptas, T., Kaygusuz-Atagunduz, I., Kani, H. T., Adiguzel, C., & Firatli-Tuglular, T.

(2014). Levofloxacin for the treatment of severe refractory BK virus-associated

hemorrhagic cystitis in hematopoietic stem cell transplantation recipients: A report of

three cases. Oncology Letters, 8, 1775-1777. A4. Ozakpinar, O. B., Maurer, A. M., Adiguzel, C., Cilingir, O. T., Demir, M., & Uras, F.

(2013). Differentiation of hematopoietic stem cells isolated from peripheral blood to

megakaryocyte. TURKISH JOURNAL OF BIOCHEMISTRY, 38(3), 243-249. A5. Fareed J, Adiguzel C, Thethi I.Hata! Köprü başvurusu geçerli değil. Thromb J.

2011 Mar 28;9(1): 5. A6. Walenga JM, Adiguzel C. Hata! Köprü başvurusu geçerli değil. Int J Clin Pract.

64(7): 956-67 (2010). A7. Kaygusuz I, Koc M, Arikan H, Adiguzel C, Cakalagaoglu F, Tuglular TF, Akoglu E.

Hata! Köprü başvurusu geçerli değil. Ren Fail. 32(2): 273-6 (2010). A8. Knesek MJ, Litinas E, Adiguzel C, Hopkinson W, Hoppensteadt D, Lassen M, Fareed

J. Hata! Köprü başvurusu geçerli değil. Clin Appl Thromb Hemost. 16(1): 42-50

(2010). A9. Zhu H, Hoppensteadt D, Iqbal O, Litinas E, Adiguzel C, Fareed J. Hata! Köprü

başvurusu geçerli değil. Clin Appl Thromb Hemost. 15(6): 681-8 (2009). A10. Adiguzel C, Iqbal O, Demir M, Fareed J. Hata! Köprü başvurusu geçerli değil.

Clin Appl Thromb Hemost. 15(6): 645-51 (2009). A11. Adiguzel, C., O. Iqbal, D. Hoppensteadt, W. Jeske, J. Cunanan, E. Litinas, H. Zhu,

J. M. Walenga and J. Fareed. “Hata! Köprü başvurusu geçerli değil. Clin Appl Thromb Hemost, 15(5): 501-11. (2009). Doi: 10.1177/1076029609338711. Epub 2009 Aug 23. A12. Sayitoglu, M., I. C. Haznedaroğlu, O. Hatirnaz, Y. Erbilgin, S. Aksu, E. Koca, C.

Adiguzel, M. Bayik, I. Akalin, Z. Gülbas, M. Akay, A. Unal, L. Kaynar, E. Ovali, M.

Yilmaz, M. Yenerel, S. Dagdas, G. Ozet, C. Ar, Y. Aydin, T. Soysal, B. Durgun, O. Ozcebe,

A. Tukun, O. Ilhan and U. Ozbek. “Hata! Köprü başvurusu geçerli değil. J Int Med

Res, 37, 1018-1028 (2009).

A13. Kannan, M., R. Saxena, C. Adiguzel and J. Fareed. Hata! Köprü başvurusu

geçerli değil. Semin Thromb Hemost, 35, 337-343 (2009).

A14. Adiguzel, C., V. Bansal, E. Litinas, J. Cunanan, O. Iqbal, K. Nelson, M. Kannan, D.

Hoppensteadt and J. Fareed. “Hata! Köprü başvurusu geçerli değil. Clin Appl Thromb

Hemost, 15, 145-151 (2009).

A15. Adiguzel, C., W. P. Jeske, D. Hoppensteadt, J. M. Walenga, V. Bansal and Fareed

J. “Hata! Köprü başvurusu geçerli değil. Clin Appl Thromb Hemost, 15, 137-144

(2009).

A16. Adiguzel, C., S. U. Bozkurt, I. Kaygusuz, A. Uzay, Tecimer T, and M. Bayik. “Hata!

Köprü başvurusu geçerli değil. APMIS, 117, 222-229 (2009).

A17. Heilmann, L., M. Schorch, T. Hahn, G. Adasz, K. Schilberz, C. Adiguzel and J.

Fareed. “Hata! Köprü başvurusu geçerli değil. Semin Thromb Hemos. 34, 794-802

(2008).

A18. Zhu, H., D. Hoppensteadt, C. Adiguzel, R. L. Bick and J. Fareed. “Hata! Köprü

başvurusu geçerli değil. Clin Appl Thromb Hemost, 15, 41-49 (2009).

A19. Zhu, H., D. Hoppensteadt, R. Wahi, J. Cunanan, C. Adiguzel, R. Bick and J.

Fareed. “Hata! Köprü başvurusu geçerli değil. Clin Appl Thromb Hemost, 15, 32-40

(2009).

4

A20. Clark, M., D. Hoppensteadt, J. Walenga, L. Myers, J. Cunanan, W. Jeske, C.

Adiguzel, O. Iqbal and J. Fareed. “Hata! Köprü başvurusu geçerli değil. Int Angiol,

27, 370-376 (2008).

A21. Iqbal, O., C. Adiguzel, B. E. Lewis, J. Cunanan and J. Hata! Köprü başvurusu

geçerli değil.“Argatroban in percutaneous Coronary interventions”. Semin Thromb

Hemost, 34(Suppl 1), 62-74 (2008).

A22. Adiguzel, C., O. Iqbal, J. Cunanan, W. Jeske, D. Hoppensteadt, J. M. Walenga and

J. Fareed. “Potency adjusted generic versions of argatroban can be differentiated

from branded argatroban in thrombin generation and platelet activation

assays”. Semin Thromb Hemost, 34(Suppl 1), 108-117 (2008).

A23. Hata! Köprü başvurusu geçerli değil. “Biological profile of the

hyper/oversulfated chondroitin sulfate contaminant isolated from recall heparin”. Semin

Thromb Hemost, 34(Suppl 1), 119-127 (2008).

A24. Hata! Köprü başvurusu geçerli değil. “Are all low molecular weight heparins

equivalent in the management of venous thromboembolism?” Clin Appl Thromb Hemost,

14, 385-392 (2008).

A25. Hata! Köprü başvurusu geçerli değil. “Contaminant in the recalled

unfractionated heparin preparations: where is the problem?” Clin Appl Thromb Hemost,

14, 261-266 (2008).

A26. Hata! Köprü başvurusu geçerli değil. “Chaining trends in anti-coagulant

therapies. Are heparins and oral anti-coagulants challenged?” Int Angiol, 27, 176-192

(2008).

A27. Hata! Köprü başvurusu geçerli değil. “Survival of heparins, oral anticoagulants,

and aspirin after the year 2010”. Semin Thromb Hemost, 34, 58-73 (2008).

A28. Hata! Köprü başvurusu geçerli değil. “Differentiating low-molecular-weight

heparins based on chemical, biological, and pharmacologic”. Semin Thromb Hemost, 34,

74-85 (2008).

A29. Hata! Köprü başvurusu geçerli değil. “Laboratory evaluation of the

antiphospholipid syndrome”. Hematol Oncol Clin North Am, 22, 19-32 (2008).

A30. Bizargity, P., C. Adıguzel, G. Ozilhan, M. Bayık and E. Eksioglu-Demiralp. “İmatinib

does not inhibit neutrophil oxidative burst function in patients with chronic myelogenous

leukemia”. Clin Lab Haem: 27: 1-2 (2005).

A31. Cetiner, M., C. Adıgüzel, D. Argon, S. Ratip, E. Ekşioğlu-Demiralp, T. Tecimer and

M. Bayık. “Hairy Cell Leukemia in Father and Son”. Med Oncol, 20, 375-378 (2003).

A32. Demirçay, Z., A. Cömert and C. Adıgüzel. “Leg Ulsers and Hydroxyurea: Report of

Three Cases with Essential Thrombocythemia”. International Journal of Dermatology, 41,

872-874 (2002).

B. Abstracts-full texts presented in and published in proceedings of

international scientific meetings:

B1. Dilvin Guney, Aysin Tulunay, Funda Pepedil, Isik Kaygusuz, Cafer Adiguzel, Tülin

Tuglular, Muzaffer Demir, Emel Eksioglu-Demiralp, and Fikriye Uras. Tyro3, Axl Ve Mer

(TAM) Receptors On Surfaces of Mononuclear Cells in Patients with B-Cell

5

Chronic Lymphocytic Leukemia. Blood (ASH Annual Meeting Abstracts), Nov 2012;

120: 4588.

B2. Debra Hoppensteadt, Hussein Khan, Indermohan Thethi, Muzaffer Demir, Cafer

Adiguzel, Saud Rahman, and Jawed Fareed. Inflammatory and Thrombotic

Mediators in Small Cell Lung Carcinoma: Potential Role in Thromboembolic

Complications. Blood (ASH Annual Meeting Abstracts), Nov 2011; 118: 2294.

B3. Jawed Fareed, Cafer Adiguzel, Debra Hoppensteadt, Walter Jeske, Jeanine M.

Walenga, Bruce E Lewis, Harry L. Messmore, Jr., and Vinod Bansal. Prevalence of

Heparin Induced Thrombocytopenia Antibodies During the Period 2004–2011.

Relevance to Heparin Contaminants. Blood (ASH Annual Meeting Abstracts), Nov

2011; 118: 4326.

B4. Microscopic Examination Of Bone Marrow Aspiration Smears: Diagnostic

Agreement Of Hematologists And Hematopathologists On Common

Hematological Diagnoses T Toptas, M Sungurtekin, G Gokoglu, M Gun, T Kasikci, G

Yilmaz, B Kantarcioglu, I Kaygusuz, C Adiguzel, S Bozkurt, T Firatli-Tuglular, M Bayik. 16th Congress of the European Hematology Association London, 2011 (1755).

B5. Levofloxacin For Bk Virus-Associated Hemorrhagic Cystitis In The Post-

Hematopoietic Stem Cell Transplantation Period T Toptas, I Kaygusuz, T Kani, B

Kantarcioglu, G Yilmaz, C Adiguzel, T Firatli-Tuglular, M Bayik. 16th Congress of the

European Hematology Association London, 2011 (1495).

B6. The Effect Of Complete Molecular Response On Progression-Free Survival In

Patients With Chronic Myeloid Leukemia Receiving Imatinib Mesylate I Kaygusuz,

T Toptas, B Kantarcioglu, G Yilmaz, C Adiguzel, E Eksioglu-Demiralp, T Firatli-Tuglular,

M Bayik 16th Congress of the European Hematology Association London, 2011 (0154). B7. Jawed Fareed, Debra Hoppensteadt, Josephine Cunanan, Walter Jeske, Cafer

Adiguzel, He Zhu, Cinara Echart, and Massimo Iacobelli. Prolonged Administration of

Defibrotide Is Non-Immunogenic in Rats and Dogs. Blood (ASH Annual Meeting

Abstracts), Nov 2009; 114: 4180. B8. Walenga, J., M. Bakhos, D. Hoppensteadt, C. Adiguzel, J. Cunanan and W. Jeske.

“Hata! Köprü başvurusu geçerli değil.”. Journal of Thrombosis and Haemostasis, 7

(Suppl 2), PP-MO-399, 2009, (XXII Congress of the International Society of Thrombosis

and Haemostasis, Boston, MA, USA, 11-16 July 2009). B9. Gray, A., D. Hoppensteadt, L. Myers, O. Iqbal, C. Adiguzel, and J. Fareed. “Hata!

Köprü başvurusu geçerli değil.”. Journal of Thrombosis and Haemostasis, 7 (Suppl 2),

PP-MO-136, 2009, (XXII Congress of the International Society of Thrombosis and

Haemostasis, Boston, MA, USA, 11-16 July 2009). B10.

Adiguzel, C., E. Litinas, J. Cunanan, D. Hoppensteadt, J. Walenga and J. Fareed. “Hata!



Haemostasis, Boston, MA, USA, 11-16 July 2009).

B11.

Adiguzel, C., J. Fareed, J. Walenga, D. Hoppensteadt, W. Jeske, O. Iqbal, J. Cunanan

and E. Litinas. “Hata! Köprü başvurusu geçerli değil.”. Journal of Thrombosis and

Haemostasis. 7 (Suppl 2), PP-MO-140, 2009, (XXII Congress of the International Society

of Thrombosis and Haemostasis, Boston, MA, USA, 11-16 July 2009).

B12.

Hoppensteadt, D., J. Fareed, V. Bansal, O. Iqbal, C. Adiguzel and H. Messmore. “Hata!


6



B13.

Bansal, V., E. Litinas, D. Hoppensteadt, C. Adiguzel and Jawed Fareed. “Hata! Köprü

başvurusu geçerli değil. Journal of Thrombosis and Haemostasis, 7 (Suppl 2), PP-TH-

145, 2009, (XXII Congress of the International Society of Thrombosis and Haemostasis,

Boston, MA, USA, 11-16 July 2009).

B14.

Bansal, V., J. Cunanan, D. Hoppensteadt, C. Adiguzel, O. Iqbal and J. Fareed. “Hata!


PP-WE-261, 2009, (XXII Congress of the International Society of Thrombosis and


B15. Adiguzel, C., J. Walenga, H. Messmore,, D. Hoppensteadt, R. Wahi, ve J. Fareed, “ Hata! Köprü başvurusu geçerli değil.”. Journal of Thrombosis and Haemostasis, 7

(Suppl 2), PP-TH-390, 2009, (XXII Congress of the International Society of Thrombosis

and Haemostasis, Boston, MA, USA, 11-16 July 2009)

B16. Litinas, E., C. Adiguzel, W. Jeske, D. Hoppensteadt, H. Messmore, J. Walenga and

J. Fareed. “ Hata! Köprü başvurusu geçerli değil.”. Journal of Thrombosis and Haemostasis, 7

(Suppl 2), PP-WE-385, 2009, (XXII Congress of the International Society of Thrombosis


B17. Walenga, J., C. Adiguzel, J. Cunanan, D. Hoppensteadt, O. Iqbal and M. Bakhos. “ Hata! Köprü başvurusu geçerli değil.”. Journal of Thrombosis and Haemostasis, 7


and Haemostasis, Boston, MA, USA, 11-16 July 2009) B18. Hoppensteadt, D., O. Iqbal, C. Adiguzel, J. Cunanan and J. Fareed. “ Hata! Köprü başvurusu geçerli değil. Journal of Thrombosis and Haemostasis, 7



B19. Iqbal, O., C. Adiguzel, J. Fareed, D. Hoppensteadt, E. Litinas, H. Zhu, and A

Halaris. “Selective Serotonin Reuptake Inhibitors Influence Agonist-Induced Platelet

Aggregation. Preliminary Results from Comorbidity of Depression and Cardiovascular

Disease Study”. Blood, 112, 4556, 2008, (50. ASH Annual Meeting Abstracts in San

Francisco, 5-9 December 2008 ).

B20. Bansal, V., J. Cunanan, C. Adiguzel, E. Litinas, K. Nelson, and J. Fareed. A Higher

“Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin”. Blood,

112, 3022, 2008, (50. ASH Annual Meeting Abstracts in San Francisco, 5-9 December

2008).

B21. Zhu, H., D. Hoppensteadt, R. L. Bick, C. Adiguzel, R. Wahi and Jawed Fareed.

“Relative Immunologic Potential of Bovine Prothrombin and Purified Thrombins”. Blood

112, 5463, 2008, (50. ASH Annual Meeting Abstracts in San Francisco, 5-9 December

2008 ).

B22. Fareed, J., D. Hoppensteadt, W. Jeske, C. Adiguzel, O. Iqbal and J. M. Walenga.

“Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin.

Impact on Anticoagulation and Potential Adverse Reactions”. Blood, 112, 4048, 2009,

(50. ASH Annual Meeting Abstracts in San Francisco, 5-9 December 2008 ).

7

B23. Adiguzel, C., V. Bansal, J. Cunanan, E. Litinas, D. Hoppensteadt and J. Fareed.

“Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients

Contributes to the Hemostatic Abnormalities”. Blood, 112, 4078, 2008, (50. ASH Annual

Meeting Abstracts in San Francisco, 5-9 December 2008 ).

B24. Adiguzel, C., V. Bansal, J. Cunanan, E. Litinas, D. Hoppensteadt and J. Fareed.

“Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease

Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated

Hemodynamic Responses”. Blood, 112, 4079, 2008, (50. ASH Annual Meeting Abstracts

in San Francisco, 5-9 December 2008).

B25. Fareed, J., O. Iqbal, D. Hoppensteadt, C. Adiguzel, M. Iacobelli and J. M. Walenga.

“Defibrotide Augments the Anticoagulant Actions of Heparin and Low Molecular Weight

Heparins”. Blood, 112: 4086, 2008;. (50. ASH Annual Meeting Abstracts in San

Francisco, 5-9 December 2008 ).

B26. Adiguzel, C., D. Hoppensteadt, J. Cunanan, R. Bick, J. Walenga and J. Fareed

“Prevalence of heparin induced thrombocytopenia antibodies in cancer patients treated

with a low molecular weight heparin”. J Clin Oncol (May 20 suppl) 26, abstr 20601,

Hata! Köprü başvurusu geçerli değil.

B27. Fareed, J., O. Iqbal, D. Fareed, D. Hoppensteadt, C. Adiguzel and J. Cunanan

“Upregulation of procalcitonin in cancer patients with venous thrombosis is independent

of sepsis”. J Clin Oncol (May 20 suppl), 26, abstr 20583, 2008, (Hata! Köprü

başvurusu geçerli değil.

B28. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan, W. Jeske, E. Ramacotti, M.

Gomes, J. Fareed, Hata! Köprü başvurusu geçerli değil.,. “Distinct batches of

branded parnaparins have differents HIT sera mediated platelet aggregation”. XXIII

World Congress of the International Union of Angiology (Oral Presentation), 93, 2008.


Gomes and J. Fareed. “Generic versions of LMWH can be differenciated in HIT sera

mediated platelet aggregation”. XXIII World Congress of the International Union of

Angiology, Athens, (Oral Presentation), 93, 2008.


Gomes, K. Nelson and J. Fareed. “The inhibition of microparticles generation, platelet

aggregation and activation by enoxaparin”. XXIII World Congress of the International

Union of Angiology (Oral Presentation), 81, 2008.

B31. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan, E. Ramacotti, M. Gomes,

K. Nelson and J. Fareed. “Danaparoid mediated inhibition of microparticles generation,

platelet aggregation and P-selectin expression”. XXIII World Congress of the

International Union of Angiology (Oral Presentation), 81, 2008.

B32. Ramacotti, E., M. Gomes, C. Adiguzel, A. Comerota, D. Hoppensteadt, A.

Nicolaides and J. Fareed. “An Open, Non-randomized, prospective clinical trial comparing

the pharmacodynamics of two enoxaparins (Barnded- Sanofi-Aventis-SA and Generic

Biochimico- Cutenox-CT), 40 mg o. D 6-14 days in acutely medically ill patients”. XXIII

World Congress of the International Union of Angiology (Oral Presentation), 82, 2008.

B33. Gomes, M., E. Ramacotti, C. Adiguzel, A. Comerota, D. Hoppensteadt, A.

Nicolaides and J. Fareed. “An Open, Non-randomized, prospective clinical trial comparing

the pharmacodynamics of two enoxaparins (Barnded- Sanofi-Aventis-SA and Generic

Biochimico- Cutenox-CT), 40 mg o. D 10 days in healthy volunteers”. XXIII World

Congress of the International Union of Angiology (Oral Presentation), 81, 2008.

8

B34. Hata! Köprü başvurusu geçerli değil., J, V. Bansal, D. Hoppensteadt, C.

Adiguzel, H. Messmore, R. Bick ve Jawed Fareed. “Decrease prevalance of antiheparin

platelet factor 4 antibodies in end steage renel disease”. XXIII World Congress of the


B35. Clark M., D. Hoppensteadt, J. Cunanan, C. Adiguzel, R. Leinhardt and J. Fareed.

“Molecular profiling of a heparinase resistant glycosaminoglycan in contaminated

heparins. Comparative studies with noncontaminated heparin and O-sulfonated

chodroitin sulfate”. XXIII World Congress of the International Union of Angiology (Oral

Presentation), 65,2008.

B36. Zhu, H., D. Hoppensteadt, J. Cunanan, C. Adiguzel, L. Bick and J. Fareed.

“Reduced immunogenic potential of membrane filtered bovine thrombine preparations for

hemostatic application”. XXIII World Congress of the International Union of Angiology

(Oral Presentation), 27, 2008.

B37. Clark, M., D. Hoppensteadt, J. Cunanan, C. Adiguzel, R. Leinhardt and J. Fareed.

“Comparative anticoagulant and antiprotease actions of O-sulfated chondroitin sulfate

(OSCS), unfractionated heparin (UFH), and their mixtures”. XXIII World Congress of the


B38. Hata! Köprü başvurusu geçerli değil., J., W. Jeske, D. Hoppensteadt, O. Iqbal,

C. Adiguzel, H. Messmore and J. Fareed. “Differential heparin-induced

thrombocytopenic potential of low molecular weight heparins”. XXIII World

Congress of the International Union of Angiology (Oral Presentation), 25, 2008.

B39. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan and J. Fareed. “Suledoxide

mediated inhibition of tissue factor activation of platelet a potential mechanism

for the observed therapeutic effects in diabetic nephropathy”. Experimental

Biology 2008, April 4- 9, San Diego, California, USA. Abst#4281, 2008.

B40. Adiguzel, C., O. Iqbal, D. Hoppensteadt, J. Cunanan and J. Fareed. “Comparative

anticoagulant effects of suledoxide and enoxaparin in citrated whole blood”.

Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#2388, 2008.

B41. Samiccannu, M. R., C. Adiguzel, O. Iqbal, D. Hoppensteadt, J. Cunanan and J.

Fareed. “The inhibition of microparticle generation by anticoagulant drugs”.

Experimental Biology 2008, April 4- 9, San Diego, California, USA. Abst#7073, 2008.

B42. Hata! Köprü başvurusu geçerli değil., D., V. Bansal, J. Cunanan, K. Patel, C.

Adiguzel, R. Wahi and J. Fareed. “Prevalence of non-specific cross-reactive epitopes to

bovine factor VA light chain fragments in end stage renal disease, acute coronary

syndrome and burn patient plasma”. Haemostaseologie (52. GTH Annual Meeting

Abstracts), A 93, 2008.

B43. Adiguzel, C., O. Iqbal, M. Sammikannu, J. Cunanan, W. Jeske, D. Hoppensteadt,

and J. Fareed. “Potency Adjusted Generic Versions of Argatroban Can Be

Differentiated from Branded Argatroban in Thrombin Generation and Platelet

Activation Assays”. Blood, 110, 4007, 2007 (49. ASH Annual Meeting Abstracts in

Atlanta, 8-12 December, 2007 ).

B44. Adiguzel, C., O. Iqbal, D. Fareed, D. Hoppensteadt, W. Jeske, M. Sammikannu and

J. Fareed. “Modulation of Platelet Function by Recombinant Thrombomodulin

Hematologic Implications”. Blood; 110, 3898, 2007, (49. ASH Annual Meeting

Abstracts in Atlanta, 8-12 December, 2007 ).

9

B45. Iqbal, O., C. Adiguzel, D. Hoppensteadt, J. Cunannan, and J. Fareed. “Factor Xa

Inhibitors Can Be Differentiated İn Xa, Iıa And Microparticle Generation And

Other Whole Blood Based Assays”. Blood, 110, 931,2007 (49. ASH Annual Meeting

Abstracts in Atlanta, 8-12 December, 2007 ).

B46. Demir, M., A. Ciftci, D. Hoppensteadt, G. Altiay, M. Tobu, O. Iqbal, D. Fareed, C.

Adiguzel, M. Kujawski and J. Fareed. “ProteinChip Array Profiling and Markers of

Inflammation and Thrombin Generation in Plasma Samples from Lung Cancer

Patients and Their Modulation by Chemotherapy with or without Warfarin

Anticoagulation”. Blood, 110, 3978, 2007, (49. ASH Annual Meeting Abstracts in


B47. Kujawski, M. R, M. Prechel, H. Zhu, J. Walenga, D. Hoppensteadt, J. Cunanan, C.

Adiguzel and J. Fareed. “A Unique Biomarker Is Associated with the Prevalence of

Functional Heparin Induced Thrombocytopenia (HIT) Associated Antibodies:

Results from Proteomic (ProteinChip Array) Profiling of ELISA Positive HIT

Plasma Samples”. Blood, 110, 3205, 2007, (49. ASH Annual Meeting Abstracts in


B48. N. Fabbrini, D. Hoppensteadt, H. Messmore, R. Bick, C. Adiguzel and J. Fareed.

“Upregulation of Microparticles and CD40 Ligand in Antiphospholipid Syndrome:

Potential Implication in Inflammatory Responses and Thrombosis”. Blood, 110,

1740, 2007 (49. ASH Annual Meeting Abstracts in Atlanta, 8-12 December, 2007 ).

B49. Adıgüzel C, Kaygusuz I, Birtaş Ateşoglu E, Noyan F, Çetiner M, Demiralp E,

Fıratli-Tuğlular T, Bayık M. Chronic Myelogenous Leukemia occurring in mother and

son. 1st International Lymphoma-Leukemia-Myeloma Congress, Abstract No: 139, page

116, Fethiye/Muğla, 24-27 May 2007

B50. Adıgüzel, C., S. Uyar-Bozkurt, T. Tecimer, E. Birtaş, I. Kaygusuz, F. Noyan, A.

Uzay and M. Bayık. “HHV-8 Negative Primary Effusion Lymphoma in a HIV Negative

Patient” XXXth World Congress of the International Society of Hematology, Istanbul,

Turkish Journal of Haematology, suppl., Vol. 22, 2005.

B51. Uzay, A., C. Adıgüzel, M. Demir, M. Bayık. “The in vitro Effect of Different

Molecular Weight Hydroxyethyl Starch Solutions and Saline on Platelet Aggregation”

XXXth World Congress of the International Society of Hematology, Istanbul, Turkish

Journal of Haematology, suppl., Vol. 22, 2005.

B52. Noyan, F., E. Birtaş, C. Adıgüzel, I. Kaygusuz, M. Çetiner,, T. Fıratlı-Tuğlular and

M. Bayık,, “A VAD Therapy Resistant Multiple Myeloma Transformed From CLL” XXXth

World Congress of the International Society of Hematology, Istanbul, Turkish Journal of

Haematology, suppl., Vol. 22, 2005.

B53. Birtaş, E., Z. Odabaşı, T. Fıratlı-Tuğlular, C. Adıgüzel, I. Kaygusuz, F. Noyan, M.

Çetiner, V. Korten and M. Bayık. “Epidemiology of Bacterial Infections in Febrile

Neutropenic Patients Having Hematological Malignancies in Marmara University Hospital,

Istanbul, Turkiye” XXXth World Congress of the International Society of Hematology,

Istanbul, Turkish Journal of Haematology, suppl., Vol. 22, 2005.

B54. Eksioglu-Demiralp,E., P. Bizargity, C. Adiguzel, G. Ozilhan and M. Bayik.

“Imatinib Does Not Inhibit Neutrophil Oxidative Burst Function in Patients with Chronic

Myelogenous Leukemia (CML)”. The American Society of Hematology 46th Annual

Meeting and Exposition, December 9-12, USA., Blood (ASH Annual Meeting Abstracts,

104: Abstract 4673 ) 2004

10

B55. Çetiner, M., S. Kalaça, S. Ratip, Ç. Yazgan, C. Adıgüzel, S. Kalayoğlu-Beşışık, D.

Argon, I. Kaygusuz, G. Aktuğlu and M. Bayık, “Quality of Life Assessment of

Haematopoietic Stem cell Transplantationpatients in Istanbul: a Pilot Study,” 30th Annual

Meeting of the European Group for Blood and Marrow Transplantation, Barcelona, Bone

Marrow Transplantation, Vol. XXXIII, 2004

B56. Adıgüzel, C., M. Sönmezoğlu, D. Argon, T. Akdeniz, E. Z. Demiralp and M. Bayık.

“Effects of irradiation and filtration on viability of platelets”. VIII European Congress of

The International Society of Blood Transfusion, Istanbul, pg24, 5-9 July 2003.

B57. Yüksel, M., D. Argon, C. Adıgüzel, M. Sönmezoğlu, M. Bayık and S. Yalçın. “Effects

of gamma irradiation and storage on apheresis platelets: The role of reactive oxygen

species”. VIII European Congress of The International Society of Blood Transfusion,

Istanbul, 5-9 July 2003, pg 5 B58. Sönmezoğlu, M., D. Argon, C. Adıgüzel and M. Bayık. “Evaluation of storage

conditions of blood bank by measuring of free hemoglobin in red cell concentrates and

whole blood”. VIII European Congress of The International Society of Blood Transfusion,

Istanbul, pg55, 5-9 July 2003. B59. Argon, D., M. Sönmezoğlu, C. Adıgüzel and M. Bayık. “Effects of prestorage

leukocyte depletion on the platelet storage lesion”. VIII European Congress of The

International Society of Blood Transfusion, Istanbul, 5-9 July 2003, pg55

B60. Kartı, S. S., S. Ratip, M. Yılmaz, S. Ukınç, A. Örem, C. Adıgüzel, F. Dane, N.

Kandemir, E. Ovalı and M. Bayık. “Therapeutic Trial of Cobalamin in Patients with Normal

Serum Cobalamin Levels and Predicted Cobalamin Deficiency”. 7 th Meeting of the

European Hematology Association, Florence, Italy, The Hematology Journal suppl., Vol. 3.

2002.

C. Books and book sections written in other languages: D. Articles published in local peer-review journals: D1. Adıgüzel, Cafer.

“Postoperative Bleeding Problems and its Treatment.” Turkiye Klinikleri Journal of

Hematology Special Topics 8.3 (2015): 43-47.

D2. Adıgüzel, C. (2014). Acquired Platelet Function Disorders (Drugs, Chronic Diseases,

Herbal Products). Turkiye Klinikleri Journal of Hematology Special Topics, 7(2), 41-45.

D3: Işık KAYGUSUZ, Bülent KANTARCIOĞLU, Tayfur TOPTAŞ, Güven YILMAZ, Cafer

Adıgüzel, Tülin Fıratlı TUĞLULAR, Emel DEMIRALP, Mahmut BAYIK. Factors Affecting

Stem Cell Mobilization in Patients Treated With Hematopoietic Peripheral Stem

Cell Transplantation. Marmara Medical Journal 2011; 24 (1): 31-37

D4. Birtaş-Ateşoğlu, E., T. Fıratlı-Tuğlular, C. Adıgüzel, I. Kaygusuz, F. Noyan, M.

Çetiner, M. Bayık. “A case of Cauda Equina syndrome in a leukemic patient due to

intrathecal methotrexate”, Tr J Haematol, 24, 28-31 (2007)

D5. Kaygusuz, I., Z. Odabaşı, C. Adıgüzel, F. Noyan, E. Birtaş, V. Korten, T. Fıratlı-

Tuğlular, M. Çetiner, M Bayık. “Complete heart block in a neutropenic patient with

invasive aspergillosis”, Tr J Haematol, 23, 205-208 (2006)

D6. Çetiner, M., T. Fıratlı-Tuğlular, Y. Özen-Al Ahdab, H. Al Ahdab, M. Köse, F. Noyan, C.

Adıgüzel, E. Ovalı, M. Bayık. “Amifostine treatment in patients with

myelodysplastic syndrome” Turk J Haematol, 22, 117-123 (2005)

D7. Çetiner, M., I. Kaygusuz, T. Tecimer, E. Arı, E. Birtaş, F. Noyan, C. Adıgüzel, T.

Fıratlı-Tuğlular, M. Bayık. “Myelodysplastic Syndrome with Pseudoreticulocytosis”, Tr J

Haematol, 22, 41-44 (2005)

11

D8. Argon, D., M. Çetiner, C. Adıgüzel, I. Kaygusuz, T. Fıratlı-Tuğlular, T. Tecimer, M.

Bayık. “Bone Marrow Necrosis in a Patient with Non-Hodgkin Lymphoma”, Turk J

Haematol, 21, 97-100 (2004)

D9. Kartı SS, S. Ratip, M. Yılmaz, S. Ukınç, A. Örem, C. Adıgüzel, F. Dane, N. Kandemir,

E. Ovalı, M. Bayık. “Therapeutic Trial of Cobalamin in Patients with Normal Serum

Cobalamin Levels and Predicted Cobalamin Deficiency”. Turk J Haematol, 20, 69-74,

(2003).

D10. Kartı, S., C. Adıgüzel, M. Yılmaz, M. Çetiner, S. Ratip, E. Ekşioğlu, S. Aktaş, N.

Sofu, Y. Elbir, E. Ovalı, M. Bayık, “Comparing two cryopreservation methods regarding

viability and colony formation potential of stem cell”, Turkish Journal of Hematology and

Oncology,4, 171-177 (2002).

D11. Kaya E, Albayrak A,Kendir T, Akdoğan F, İyikesici S, Uğur B, Masatlıoğlu S, Erten E,

Adıgüzel C. Relations between leukocyte, granulocyte, erythrocyte and platelet counts in

perpiheral blood ad diameter of splenic vein in splenomegalies secondary to various

etiologies. Haydarpaşa Numune Hospital, Medical Journal, 1996: 36(1): 37-43. E. Abstracts-full texts presented and published in proceedings of local scientific meetings E1. Adıgüzel, C., M. Bayık, A-M. Maurer, A. Tolunay, E. Birtaş-Ateşoğlu, I. Kaygusuz, F.

Atalay, M. Çetiner, T. Fıratlı-Tuğlular, H. Direskeneli, E. Ekşioğlu-Demiralp, “Mature

Endothelium, Active Endothelium and Endothelial Progenitor Cell Counts in Patients with

Behçet’s Diseases and Thrombosis”, XXXII. Turkish Hematology Congress, Proceedings,

10, Antalya, 2006

E2. Birtaş-Ateşoğlu, E., F. Atalay, A. Uzay, I. Kaygusuz, C. Adıgüzel, M. Çetiner, T.

Fıratlı-Tuğlular, M. Bayık. “Primary Thyroid Lymphoma – Case Report”, XXXII. Turkish

Hematology Congress, Proceedings, 215, Antalya, 2006

E3. Adıgüzel, C., I. Kaygusuz, F. Atalay, E. Birtaş-Ateşoğlu, A. Uzay, M. Çetiner, T.

Fıratlı-Tuğlular, M. Bayık. “Imatibine-Mesilat in a patient with CML who presents with

Relapse 13 Years after Allogeneic Bone Marrow Transplantation”, XXXII. Turkish

Hematology Congress, Proceedings, 276, Antalya, 2006

E4. Kaygusuz, I., C. Adıgüzel, I. Köker, F. Atalay, E. Birtaş-Ateşoğlu, A. Uzay, T.

Tecimer, M. Çetiner, T. Fıratlı-Tuğlular, M. Bayık. “Bone Marrow Necrosis in a patient with

CML who receives Glivec”, XXXII. Turkish Hematology Congress, Proceedings, 275,

Antalya, 2006

E5. Kaygusuz, I., F. Yumuk, C. Adıgüzel, F. Atalay, E. Birtaş-Ateşoğlu, HB. Çağlar, M.

Çetiner, T. Fıratlı-Tuğlular, M. Bayık. “Breast cancer in a patient with CML who receives

Glivec”, XXXII. Turkish Hematology Congress, Proceedings, 274, Antalya, 2006

E6. Kaygusuz, I., M. Koç, C. Adıgüzel, E. Birtaş-Ateşoğlu, F. Atalay, A. Uzay, M. Çetiner,

T. Fıratlı-Tuğlular, M. Bayık. “Focal Segmented Glomerulosclerosis in the course of

idiopathic myelofibrosis”, XXXII. Turkish Hematology Congress, Proceedings, 290,

Antalya, 2006

E7. Atalay, F., E. Birtaş-Ateşoğlu, I. Kaygusuz, C. Adıgüzel, A. Uzay, T. Fıratlı-Tuğlular,

M. Çetiner, M. Bayık. “Evaluating toxicity of Thalidomide in patients with Multiple

Myeloma”, XXXII. Turkish Hematology Congress, Proceedings, 301, Antalya, 2006

E8. Kaygusuz, I., C. Adıgüzel, F. Atalay, E. Birtaş-Ateşoğlu, A. Uzay, M. Çetiner, T.

Fıratlı-Tuğlular, M. Bayık, “Evaluating toxicity of bortezomib in patients with Multiple

Myeloma”, XXXII. Turkish Hematology Congress, Proceedings, 303, Antalya, 2006

12

E9. Noyan, F, C. Adıgüzel, T. Fıratlı-Tuğlular, I. Kaygusuz, E. Birtaş, M. Çetiner, M.

Bayık. “Our experiences with Glives in patients with CML”, XXXI. Turkish Hematology

Congress, Proceedings, 120, Antalya, 2004

E10. Çetiner, M., E. Birtaş, C. Adıgüzel, I. Kaygusuz, T. Fıratlı-Tuğlular, M. Bayık.

“Transfusion Standards and Quality Supervision in Hematology Clinics located at

Marmara Region”, XXXI. Turkish Hematology Congress, Proceedings (oral), 44-45,

Antalya, 2004

E11. Çetiner, M., H. Beköz, C. Adıgüzel, F. Noyan, İ. Karadoğan, I. Kaygusuz, A.

Timuroğlu, T. Fıratlı-Tuğlular, L. Ündar. “Toxicity profile of Hiper-CVAD chemotherapy in

management of acute lymphoblastic leukemia and Lymphoblastic Lymphoma (Two

Center Experience). XXXI. Turkish Hematology Congress, Proceedings, 139, Antalya,

2004

E12. Birtaş, E., C. Adıgüzel, I. Kaygusuz, F. Noyan, M. Çetiner, T. Fıratlı-Tuğlular, M.

Bayık. “Prevalance of Thrombo-hemorrhagic complications in patients with polycythemia

rubra and essential thrombocytemia. XXXI. Turkish Hematology Congress, Proceedings,

148, Antalya, 2004

E13. Çetiner, M., I. Kaygusuz, E. Birtaş, C. Adıgüzel, F. Noyan, T. Tecimer, T. Fıratlı-

Tuğlular, M. Bayık. “Myelodysplastic Syndrome and Pseudoreticulocytosis (Case Report)”,

XXXI. Turkish Hematology Congress, Proceedings, 140, Antalya, 2004

E14. Kaygusuz, I., Z. Odabaşı, T. Fıratlı-Tuğlular, V. Korten, C. Adıgüzel, D. Argon, F.

Noyan, M. Çetiner, M. Bayık. “Atrioventricular block in a neutropenic patient in the couse

of invasive aspergillosis”, XXXI. Turkish Hematology Congress, Proceedings, 186,

Antalya, 2004

E15. Birtaş, E., T. Fıratlı-Tuğlular, I. Kaygusuz, F. Noyan, C. Adıgüzel, M. Çetiner, M.

Bayık. “Cauda Equina syndrome secondary to intrathecal methotrexate in an ALL patient.

Case Report”, XXXI. Turkish Hematology Congress, Proceedings, 78, Antalya, 2004

E16. Adıgüzel, C., M. Sönmezoğlu, D. Argon, T. Akdeniz, E. Demiralp, M. Bayık. “'Flow'

cytometric analysis of effects of leukocyte filtration, irradiation and storage periods on

platelet activation and apoptosis in platelet suspensions”. XXX. Turkish Hematology

Congress, Proceedings (oral presentation), 74, Istanbul, 2003

E17. Argon, D., M. Çetiner, C. Adıgüzel, I. Kaygusuz, T. Fıratlı-Tuğlular, T. Tecimer, M.

Bayık. “Case Report: Diffuse Bone Marrow Necrosis in a patient with Diffuse B Cell

Lymphoma”. XXX. Turkish Hematology Congress, Proceedings, 159, Istanbul, 2003 E18. Argon, D., M. Yüksel, C. Adıgüzel, M. Sönmezoğlu,, S. Yalçın, M. Bayık. “Effects of

leukocyte depletion, irradiation and storage times of apheresis platelet suspensions on

free radical formation”. XXX. Turkish Hematology Congress, Proceedings (oral

presentation), 74-75, Istanbul, 2003

E19.. Kaygusuz, I., M. Çetiner, S. Yapalı, C. Adıgüzel, D. Argon, P. Globi, Ş. Yavuz, T.

Tecimer, T. Fıratlı, M. Bayık, “Common variable” immune deficiency and lymphoma (for

two cases). XXX. Turkish Hematology Congress, Proceedings, 132, Istanbul, 2003

E20. Birtaş, E., T. Fıratlı-Tuğlular, V. Korten, L. Mülazımoğlu, C. Adıgüzel, D. Argon, I.

Kaygusuz, M. Çetiner, M. Bayık, “Retrospective evaluation of invasive fungal infections

that develop in patients with hematological malignancy”, XXX. Turkish Hematology

Congress, Proceedings, 160, Istanbul, 2003

13

E21. Kaygusuz, I., M. Çetiner, D. Morkoyun, D. Argon, C. Adıgüzel, T. Tecimer, T.

Fıratlı-Tuğlular, M. Bayık, “CD 7 (+) Stem Cell Lymphoma: Case Report”, XXX. Turkish

Hematology Congress, Proceedings, 132, Istanbul, 2003

E22. Argon, D., M. Çetiner, C. Adıgüzel, I. Kaygusuz, S. Ratip, M. Bayık, “Case Report:

Congenital Dyserithropoietic Anemia Type II (HEMPAS)”, XXIX. Turkish Hematology

Congress, Proceedings, Vol. IX, 184, Antalya, 2002

E23. Adıgüzel, C., M. Çetiner, D. Argon, I. Kaygusuz, S. Ratip, T. Fıratlı Tuğlular, T.

Tecimer, M. Bayık, “Large Cell Lymphoma developed on background of splenic marginal

zone lymphoma in a patient who presented with spontaneous splenic rupture”, XXIX.

Turkish Hematology Congress, Proceedings, Vol. IX, 184, Antalya, 2002

E24. Argon, D., M. Çetiner, I. Kaygusuz, C. Adıgüzel, T. Fıratlı-Tuğlular, M. Bayık, “Case

Report: A Burkitt Lymphoma Case with Isolated Thyroid Gland Involvement (Stage IE)”,

XXIX. Turkish Hematology Congress, Proceedings, Vol. IX, 184, Antalya, 2002

E25. Şeker, M., C. Gemici, Y. Koç, Ş. Güler, H. Sargın, M. Tekçe, T. Salepçi, C.

Adıgüzel, A. Yayla, “Multiple Myeloma Developed in the Course of Stomach Cancer”

XXIX. Turkish Hematology Congress, Proceedings, Vol. IX, 385, Antalya, 2002

E26. Çetiner, M., AM. Maurer, P. Bizargity, D. Argon, C. Adıguzel, E. Eksioglu-Demiralp,

M. Bayık, “Effect of somatostanin on K567 cell series and cell proliferation in bone

marrow with CML (preliminary study)”. XXIX. Turkish Hematology Congress, Proceedings,

Vol. IX, 385, Antalya, 2002 E27. Savcı, D., Ataizi, Ç. Çelikel, E. Kotiloğlu, H. Al Ahdab, C. Adıgüzel, M. Çetiner, T.

Çelikel, “Obliterative Bronchiolitis in a Graft-Versus-Host Patient: Case Report”, XV.

Turkish Pathology Congress, Proceedings, Adana, 2001. E28. Adıgüzel, C., S. Ratip, E. Ekşioğlu, M. Çetiner, S. Kartı, S. Argon, T. Fıratlı-

Tuğlular, M. Bayık, “”Pure Red Cell” Aplasia and Myasthenia Gravis in sisters with familial

thymoma”, XXVIII. Turkish Hematology Congress, Proceedings, 31, Izmir, 2000

E29. Kartı, S., C. Adıgüzel, M. Çetiner, S. Ratip, E. Ekşioğlu, S. Aktaş, N. Sofu, Y. Elbir,

E. Ovalı, M. Bayık, “Comparing Stem Cells that are cryopreserved using programmed and

mechanical cryopreservation methods regarding viability and colony formation”, XXVIII.

Turkish Hematology Congress, Proceedings, 184, Izmir, 2000

E30. Kartı, S., C. Adıgüzel, M. Çetiner, S. Ratip, E. Ekşioğlu, S. Aktaş, N. Sofu, Y. Elbir,

E. Ovalı, M. Bayık, “Effect of Pre-cryopreservation Cell Concentration on Viability and

Colony Formation Capacity of Cell”, XXVIII. Turkish Hematology Congress, Proceedings,

187, Izmir, 2000

E31. Ratip, S., C. Adıgüzel, E. Ekşioğlu, M. Çetiner, S. Kartı, D. Argon, T. Fıratlı-

Tuğlular, M. Bayık, “Familial Hairy Cell Leukemia”, XXVIII. Turkish Hematology Congress,

Proceedings, 32, Izmir, 2000

E32. Çetiner, M., E. Ovalı, M. N. Yavuz, S. Ratip, S. Kartı, C. Adıgüzel, D. Argon, T.

Fıratlı-Tuğlular, M. Bayık, “Role of Amifostine (WR-2721) on Preventing Negative Effect of

Radiation (Ex Vivo Çalışma)”. XXVIII. Turkish Hematology Congress, Proceedings, 322,

Izmir, 2000

E33. Çetiner, M., E. Ovalı, M. N. Yavuz, S. Ratip, S. Kartı, C. Adıgüzel, D. Argon, T.

Fıratlı-Tuğlular, M. Bayık, “Effect of Amifostine (WR-2721) on Healthy Bone Marrow”,

XXVIII. Turkish Hematology Congress, Proceedings, 323, Izmir, 2000

14

E34. Çetiner, M., Y. Özen, M. Köse, S. Kartı, C. Adıgüzel, D. Argon, S. Ratip, T. Fıratlı-

Tuğlular, E. Ovalı, M. Bayık, “Use of Amifostine (WR-2721) in Myelodysplastic Syndrome

Cases”, XXVIII. Turkish Hematology Congress, Proceedings, 30, Izmir, 2000

E35. Adıgüzel, C., E. Kaya, N. Adıgüzel, N. Türkel, S. Çakır, A. Albayrak. “Serum iron

and ferritin levels in ischemic heart disease”. XV. Turkish Cardiology Congress,

Proceedings, 293, Izmir, 1999

E36. Çakır, S., S. Masatlıoğlu, S. Erten, C. Adıgüzel, H. Tepeli, F. Akdoğan, A. Albayrak.

Postoperative platelet count changes in various surgeries. XXV. Turkish HEmatology

Congress, Proceedings, 201, İstanbul, 1997.

E37. Kaya, E., F. Akdoğan, N. Türkel, C. Adıgüzel, A. Albayrak. A report of case with

large granular lymphocytic leukemia. XXV. Turkish Hematology Congress, Proceedings,

290, İstanbul, 1997.

F. Other Publications: F1. Mustafa Çetiner, Mahmut Bayık. Division of Hematology,

School of Medicine, Marmara University. Diagnosis and Treatment Protocols for

Hematological Malignancies and Bone Marrow Transplantation 2000 (Handbook)

(contributed by)

F2. Mustafa Çetiner. Diagnosis and Treatment Protocols for Hematological Malignancies

and Bone Marrow Transplantation 2002 (Handbook) (contributed by) G. Visiting speaker in congress, course and meeting G1. Fibrinolytic System – Preanalytical Procedures and Laboratory Methods. Turkish

Hematology School, Hemostasis- Thrombosis Laboratory Training 2, June 24-26, 2011,

Sivas

G2. Thrombosis at Abnormal Location, “37th Turkish Hematology Congress” Ankara

Sheraton Hotel and Congress Center, October 19-22, 2011

G3. Thrombocytopenia secondary to heparin. Turkish Thorax Society, Critical Care

Symposium, October 6-8, 2011, Istanbul.

G4. Approach to patient with bleeding diathesis. Turkish Pulmonary Medicine Competency Committee, Pulmonary Medicine Specialty Training

Program, Medical School Hospital, Marmata University, Pendik, November 18-19, 2011

G5. Treatment and prophylaxis of thrombosis. Turkish Pulmonary Medicine Competency

Committee, Pulmonary Medicine Specialty Training Program, Medical School Hospital,

Marmata University, Pendik, November 18-19, 2011

G6. Indications of Transfusion. Turkish Blood Centers and Transfusion Medicine

Congress, December 14-18, 2011, Antalya

G7. Coagulation Mechanism. 5th Turkish Blood Centers and Transfusion Medicine

Congress, November 18-22, 2012, Antalya

G8. Bone Marrow Transplantation. Organ Transplantation Symposium, School of

Medicine, Marmara University. January 19, 2013 Istanbul.

curriculum vitae and lists of publications curriculum … · 1- quality of life assessment of adult...

Documents